- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02828228
Vitamin D Supplementation in Vitamin D Deficient Obese Children During Weight-loss Program
Long-term Effects of Vitamin D Supplementation in Vitamin D Deficient Obese Children During Integrated Weight-loss Program - a Double Blind Placebo Controlled Study
- Analyze the influence of vitamin D supplementation in obese children during weight-loss program on BMI, body composition and bone mineral density.
- Analyze the influence of vitamin D supplementation on the risk profile of obesity-related complications, namely impaired tolerance of glucose, insulin resistance, dyslipidemia and arterial hypertension, in obese children participating in weight-loss program.
- Analyze the prevalence of vitamin D deficiency among obese children.
- Analyze the risk factors of vitamin D deficiency in obese children (age, gender, pubertal status).
Study Overview
Detailed Description
The study will be conducted as a continuation and development of "6-10-14 for Health" program. The first phase of the program, financed by the municipality of Gdansk, was conducted in 2011-2013. The program comprised of screening and survey conducted among all 6-, 10- and 14-year-old children attending primary and grammar schools. A total of 18 162 children (including 7 448 6-year olds, 6 720 10-year olds and 3 994 14-year olds) were examined. A group of children with risk factors of civilization-related diseases (overweight and obesity defined according to BMI percentile charts. was identified on the basis of the screening. This group included 2 798 (16.32%) children, among them 9.17% of 6-years of age, 19.30% of 10-years and 20.48% of 14-years). All these children were qualified to intervention and education program. A total of 1 627 children qualified on the basis of screening eventually took part in the first edition of the program.
A total of 4 meetings with participating children and their caregivers were scheduled during the 12-month-long education and intervention program: at enrollment, and 3, 6 and 12 months thereafter. The meetings had form of individual consultations with various specialists. The first visit included complex medical examination, discussion on a health status of a child, interpretation of laboratory findings, and consultations with dietician, psychologist and physical education specialist. After consulting all the specialists involved in the program, individual protocol of health intervention was developed for every child. The objectives of the intervention included modification of diet, increasing health activity level and strengthening of health-seeking behaviors of child's family members. Adherence to the protocol and achieved results were evaluated during follow-up meetings with the specialists, and constituted the basis for development of individualized intervention plans for subsequent months.
The preliminary evaluation of the program effects was conducted in the group of 300 participants. The average percentile of BMI at enrollment to the program and after 12 months of participation amounted to 92.96 and 88.83, respectively. Participation in the program was reflected by a significant decrease in BMI percentile (p=0.0001), as well as by a significant drop off in fat mass content measured by bioelectrical impedance, from 39.0% to 31.4% (p=0.0001).
On the basis of these findings, the municipality of Gdansk decided to support the program for 2014-2016.
The experiment will follow a pattern of double blind randomized study. The enrolled subjects will be randomly assigned to one of the two groups:
Group 1 - weight-loss program for 52 weeks + vitamin D 1200 (IU) daily for 26 weeks Group 2 - weight-loss program for 52 weeks +placebo daily for 26 weeks
Visit I: enrollment:
- medical history, physical examination
- interpretation of laboratory findings (the tests conducted during screening + concentration of vitamin D),
- anthropometric evaluation and analysis of body composition (bioimpedance method)
- consultation of dietician, psychologist and specialist of physical activity, and defining detailed protocol of intervention
- Kasch Pulse Recovery Test
- determination of hs-C-reactive protein, Interleukin 6, chemerin and adiponectin concentrations in blood samples obtained during screening
- informing parents about the objectives and protocol of the study
- obtaining written informed consent for participation in the study
- randomization to GROUP I or II
- densitometry (DXA) - within one week after enrollment
Visit II: after 13 weeks:
- medical history, physical examination
- anthropometric evaluation and analysis of body composition (bioimpedance method)
- consultation of dietician, psychologist and specialist of physical activity, and defining detailed protocol of intervention
Within a week prior to Visit III - obtaining blood (ca. 5 ml) for laboratory testing (complete blood count, lipid profile, hs-C-reactive protein, oral glucose tolerance test, insulin, Interleukin 6, adiponectin and chemerin concentrations
Visit III: after 26 weeks:
- medical history, physical examination
- interpretation of laboratory findings
- anthropometric evaluation and analysis of body composition (bioimpedance method)
- consultation of dietician, psychologist and specialist of physical activity, and defining detailed protocol of intervention
- obtaining blood for laboratory testing
- termination of active compound/placebo administration
Visit IV: after 52 weeks:
- medical history, physical examination
- anthropometric evaluation and analysis of body composition (bioimpedance method)
- consultation of dietician, psychologist and specialist of physical activity, and defining detailed protocol of intervention
- densitometry (DXA) - within one week after terminating the study
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Magdalena Słominska-Frączek, MD,
- Phone Number: 694844420
- Email: fraczek@gumed.edu.pl
Study Contact Backup
- Name: Agnieszka Jankowska, MD, PhD
- Phone Number: 48606335246
- Email: ajankowska@gumed.edu.pl
Study Locations
-
-
Pomorskie
-
Gdansk, Pomorskie, Poland, 80-210
- Recruiting
- IUCCGdansk
-
Contact:
- Agnieszka Szlagatys, MD, PhD
- Phone Number: 601622894
- Email: aga1@gumed.edu.pl
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- overweight (BMI between the 85th and 95th percentile) or obesity (BMI > 95th percentile), identified on the basis of anthropometric parameters
- blood concentration of 25(OH)D3 < 30 ng/ml
- written consent of legal guardians
Exclusion Criteria:
- Chronic conditions (asthma or allergies, inflammatory diseases of connective tissue, gastrointestinal disorders, diseases of kidneys and liver, disorders of bone metabolism)
- Contraindications to administration of vitamin D
- Administration of any preparation containing vitamin D, calcium, or steroid hormones during 3 months preceding the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Vitamin D 1200 IU
Supplementation with vitamin D (1200 IU) once a day for 26 weeks
|
Vitamin D 1200 IU once a day for 26 weeks
Other Names:
|
Placebo Comparator: Placebo
Placebo once a day for 26 weeks
|
placebo once a day for 26 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Bone mineral density
Time Frame: 12 months
|
Increase in bone mineral density during weight-loss program and vitamin D supplementation
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood level of vitamin D
Time Frame: 12 months
|
Changes in blood level of vitamin D after supplementation
|
12 months
|
Arterial blood pressure
Time Frame: 12 months
|
Change in blood pressure afer weight-loss and vitamin D supplementation
|
12 months
|
Lipid profile
Time Frame: 12 months
|
Change of lipid profile after weight-loss and vitamin D supplementation
|
12 months
|
Oral Glucose Tolerance Test
Time Frame: 12 months
|
Change of biochemical parameters after weight-loss and vitamin D supplementation
|
12 months
|
Chemerin
Time Frame: 12 months
|
Change in chemerin level
|
12 months
|
BMI (kg/m2)
Time Frame: 12 months
|
Change of BMI during 12-months weight loss-program and supplementation of vitamin D
|
12 months
|
Fat mass (kg)
Time Frame: 12 months
|
Change in fat free mass during 12-months weight-loss programme and supplementation of vitamin D
|
12 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Agnieszka Szlagatys-Sidorkiewicz, MD, PhD, University Clinical Centre, Gdańsk
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 01/2016/UCK
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuNot yet recruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on Vitamin D 1200 IU
-
International Medical UniversityCompleted
-
Fundación Cardiovascular de ColombiaUniversidad Industrial de Santander; Farma de Colombia SACompletedVitamin D Deficiency | Overweight and Obesity | Overweight AdolescentsColombia
-
Cornell UniversityArogyavaram Medical CentreNot yet recruiting
-
Leho RipsUniversity of Tartu; Estonian Defence ForcesCompleted
-
Johns Hopkins UniversityNational Institute on Aging (NIA)TerminatedVitamin D Deficiency | FallsUnited States
-
National Institute of Diabetes and Digestive and...Completed
-
Augusta UniversityCompletedObesity | Overweight | Vitamin D DeficiencyUnited States
-
University of PittsburghNational Institutes of Health (NIH); National Institute on Aging (NIA)CompletedOsteoporosis | Bone Loss | Fragility FracturesUnited States
-
Rambam Health Care CampusUnknown
-
Mothaffar RimawiTerminated